Suppr超能文献

肺动脉高压中血管性血友病因子主要亚基的异常降解

Abnormal degradation of von Willebrand factor main subunit in pulmonary hypertension.

作者信息

Lopes A A, Maeda N Y

机构信息

Heart Institute, University of São Paulo, Brazil.

出版信息

Eur Respir J. 1995 Apr;8(4):530-6.

PMID:7664849
Abstract

We wished to investigate whether the abnormalities in multimeric structure and biological function of von Willebrand factor (vWF) observed in pulmonary hypertensive patients could be related to increased proteolytic degradation. We therefore analysed plasma vWF subunit composition in 24 pulmonary hypertensive patients, aged 1.2-45 yrs. After immunoisolation, vWF was subjected to 5.5% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) followed by Western immunoblotting, vWF intact subunit (225 kDa) and four proteolytic fragments (189, 176, 150 and 140 kDa) were visualized by peroxidase staining and analysed in a laser densitometer. In pulmonary hypertensive patients, the relative density of the intact subunit was decreased, and this was associated with an increase in the 176 kDa proteolytic fragment. The mean densities of the other fragments were not significantly changed, but in some patients the 150 and 140 kDa polypeptides were markedly increased. Abnormalities in multimeric structure of vWF (loss of high molecular weight multimers and increase in low molecular weight forms in comparison with controls), were associated with a significant decrease in biological activity (62-92% activity, 95% confidence interval (CI) for the mean). Total proteolytic fragment density correlated positively with multimeric abnormalities (rs = 0.45), and negatively with biological activity of vWF (rs = -0.49). Thus, in pulmonary hypertension, multimeric abnormalities and decreased biological activity are related to proteolytic degradation of vWF main subunit, possibly reflecting extensive endothelial dysfunction.

摘要

我们希望研究在肺动脉高压患者中观察到的血管性血友病因子(vWF)多聚体结构和生物学功能异常是否与蛋白水解降解增加有关。因此,我们分析了24例年龄在1.2至45岁之间的肺动脉高压患者的血浆vWF亚基组成。免疫分离后,vWF进行5.5%十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE),随后进行Western免疫印迹,通过过氧化物酶染色观察vWF完整亚基(225 kDa)和四个蛋白水解片段(189、176、150和140 kDa),并在激光密度计中进行分析。在肺动脉高压患者中,完整亚基的相对密度降低,这与176 kDa蛋白水解片段的增加有关。其他片段的平均密度没有显著变化,但在一些患者中,150和140 kDa多肽明显增加。vWF多聚体结构异常(与对照组相比,高分子量多聚体丢失和低分子量形式增加)与生物学活性显著降低(62-92%活性,平均95%置信区间(CI))相关。总蛋白水解片段密度与多聚体异常呈正相关(rs = 0.45),与vWF生物学活性呈负相关(rs = -0.49)。因此,在肺动脉高压中,多聚体异常和生物学活性降低与vWF主要亚基的蛋白水解降解有关,可能反映了广泛的内皮功能障碍。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验